All lobbying filings

THEGROUP DC, LLC

Lobbying for ASTELLAS PHARMA US, INC · Pharmaceutical research and manufacturing company.

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 20, 2026

Income

$70,000

What the client paid this registrant for the period.

Client based in

Illinois

Official filing document

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 2

Pharmacy

H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.

Health Issues

H.Res.1090, Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month" Issues related to the treatment of menopause and womens health at mid-life.

Bills named in this filing 1

H. Res. 1090
Expressing support for the designation of February 2026 as "Low Vision and Vision Impairment Awareness Month".

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.